When with @tombergk we incorporated @expressionedits in 2021 I remember we published some of the early findings on @X and were flooded with expressions of interests by fellow researchers and biotech entrepreneurs to collaborate, which was great: the truest form (especially in biotech) of demonstration that what you are building has value. You want interested stakeholders to part with something of value to see you further the development of the technology. In the beginning it could be a little cash, research resources, time, brand equity. However the holy grail remains securing your first sophisticated partnership agreement with one of the dozen pharma giants and for that your proposition needs even more depth. Very proud to have had a seat to observe and share my viewpoint on this beautiful journey, very proud of Kärt's leadership and Rebecca's hustle in bagging this biggie. We are officially in business! 🫀